PNC Financial Services Group’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.82K | Sell |
1,561
-5
| -0.3% | -$15 | ﹤0.01% | 4152 |
|
|
2025
Q1 | $5.47K | Buy |
1,566
+902
| +136% | +$3.15K | ﹤0.01% | 4030 |
|
|
2024
Q4 | $2.17K | Sell |
664
-13
| -2% | -$43 | ﹤0.01% | 4261 |
|
|
2024
Q3 | $2.61K | Buy |
677
+13
| +2% | +$50 | ﹤0.01% | 4222 |
|
|
2024
Q2 | $2.05K | Buy |
664
+456
| +219% | +$1.41K | ﹤0.01% | 4251 |
|
|
2024
Q1 | $537 | Hold |
208
| – | – | ﹤0.01% | 4486 |
|
|
2023
Q4 | $520 | Buy |
+208
| New | +$520 | ﹤0.01% | 4409 |
|
|
2018
Q4 | – | Sell |
-28,188
| Closed | -$266K | – | 4017 |
|
|
2018
Q3 | $266K | Sell |
28,188
-39,417
| -58% | -$372K | ﹤0.01% | 2038 |
|
|
2018
Q2 | $493K | Buy |
+67,605
| New | +$493K | ﹤0.01% | 1656 |
|
|
2015
Q3 | – | Sell |
-400
| Closed | -$5K | – | 4603 |
|
|
2015
Q2 | $5K | Hold |
400
| – | – | ﹤0.01% | 4058 |
|
|
2015
Q1 | $7K | Sell |
400
-500
| -56% | -$8.75K | ﹤0.01% | 3906 |
|
|
2014
Q4 | $14K | Sell |
900
-10,500
| -92% | -$163K | ﹤0.01% | 3258 |
|
|
2014
Q3 | $240K | Buy |
+11,400
| New | +$240K | ﹤0.01% | 1882 |
|